Skip to content
AwardedSpainGoods

ADQUISICIÓN DE MEDICAMENTOS EXCLUSIVOS: LISDEXANFETAMINA DIMESILATO (ELVANSE), FRUQUINTINIB (FRUZAQLA).

Published
Published 25 June 2026

Overview

ADQUISICIÓN DE MEDICAMENTOS EXCLUSIVOS: LISDEXANFETAMINA DIMESILATO (ELVANSE), FRUQUINTINIB (FRUZAQLA).

Key details

Country
Spain
Status
Awarded
Category
Goods
Procedure
Direct
Published
25 June 2026
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
€40,213
Award date
30 March 2026
Contract period
— → 26 September 2026
Winner
  • TAKEDA FARMACEUTICA ESPAÑA, S.A.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    25 June 2026

Contracting authority

  • Servicio Madrileno de Salud, Hospital Universitario La Paz

    Procuring entity

    Madrid, Spain

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: ADQUISICIÓN DE MEDICAMENTOS EXCLUSIVOS: LISDEXANFETAMINA DIMESILATO (ELVANSE), FRUQUINTINIB (FRUZAQLA). — won by TAKEDA FARMACEUTICA ESPAÑA, S.A. — Skim